Cutera, Inc. Receives Health Canada Approval for Excel V(TM) Laser System

BRISBANE, Calif., Oct. 5, 2011 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR - News), a leading worldwide provider of laser and light-based aesthetic systems for practitioners worldwide, today announced Health Canada approval for its Excel V laser. The Excel V system provides a technological breakthrough for the most common procedures of an aesthetic dermatologist’s practice -- vascular, pigment, and overall skin rejuvenation treatments.

“We are pleased to provide the Excel V system to clinicians in Canada. Featuring a dual wavelength platform, this premium workstation targets skin imperfections, including diffuse redness, spider and leg veins, and photo rejuvenation, which are the mainstays of dermatology treatments,” stated Kevin Connors, president and CEO of Cutera.

The Excel V laser offers a significant advancement versus currently available lasers. At the touch of a button, and guided by built-in navigation, physicians can easily treat a broader range of vascular and pigmented indications. One ergonomic handpiece features both a 532 nm laser, optimized for superficial vessels and pigments, and a 1064 nm Nd:YAG laser, proven to treat challenging vascular conditions, such as leg veins, port wine stains and hemangiomas (capillary abnormalities). The second handpiece, Genesis V, for facial rejuvenation, affords a gentle and collagen-producing solution for fine lines, uneven texture and premature aging without downtime.

Roy Geronemus, M.D., director of the Laser and Skin Surgery Center of New York, said, “I am pleased to offer a broader range of aesthetic options to my patients with the new, versatile Excel V laser. With the high-powered 532 nm, green wavelength, I can treat veins on the face, chest and legs with therapeutic fluences at short pulses and large spot sizes. At the same time, the 1064 Nd:YAG wavelength is optimal for treating leg veins and other vascular abnormalities. Patient comfort during treatments is maximized with adjustable contact cooling before, during and after each therapeutic pulse.”

Excel V is designed for the optimal clinician and patient experience. The ergonomic handpieces on the Excel V laser integrate optimized visibility through its unique sapphire window with real-time calibration and spot size adjustment, enabling unique precision for each targeted lesion. With a solid state design, there are no long wait times or costly consumables, such as cryogen spray, hazardous dye kits or fiber replacements that are associated with current systems.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995: Specifically, statements concerning the features, effectiveness, treatable conditions, and the potential market size for Cutera’s new product, are forward-looking statements within the meaning of the Safe Harbor. Such forward-looking statements are subject to risks and uncertainties and may be affected by various factors that may cause actual results to differ materially from those in the forward-looking statements and those other factors described in the section entitled, “Risk Factors,” in Cutera’s most recent Form 10-Q as filed with the Securities and Exchange Commission on August 1, 2011. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Contact:

Cutera, Inc.Ron SantilliChief Financial Officer415-657-5500Investor RelationsJohn MillsIntegrated Corporate Relations, Inc.310-954-1100john.mills@icrinc.com

MORE ON THIS TOPIC